Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance

Fig. 3

Cumulative incidence of hepatocellular carcinoma based on the achievement of HBsAg seroclearance. No significant difference was observed in the cumulative incidence of HCC between HBsAg seroclearance and sustained HBsAg-positive groups. HCC, hepatocellular carcinoma. P values were determined using log-rank testing

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us